共 50 条
- [21] SEQUENTIAL ENDOLUMINAL CABAZITAXEL AND GEMCITABINE WITH PEMBROLIZUMAB FOR DOCETAXEL-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE UPPER AND LOWER URINARY TRACTSJOURNAL OF UROLOGY, 2022, 207 (05): : E489 - E490Packiam, Vignesh T.McElree, IanSteinberg, Ryan L.Prescott, AdamGarje, RohanZakharia, YousefO'Donnell, Michael A.
- [22] Developments in conservative treatment for BCG-unresponsive non-muscle invasive bladder cancerEXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (10) : 1335 - 1348Dutto, DanieleLivoti, SimoneSoria, FrancescoGontero, Paolo
- [23] Sequential intravesical gemcitabine and docetaxel in the treatment of BCG-naive patients with non-muscle invasive bladder cancer.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)Thomas, LewisSteinberg, RyanNepple, Kenneth GerardO'Donnell, Michael A.
- [24] Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder TumorCANCERS, 2024, 16 (14)McElree, Ian M.Packiam, Vignesh T.Steinberg, Ryan L.Hougen, Helen Y.Mott, Sarah L.Abou Chakra, MohamadZakharia, YousefO'Donnell, Michael A.
- [25] Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive TrialsCLINICAL CANCER RESEARCH, 2020, 26 (04) : 882 - 891Kates, MaxMatoso, AndresChoi, WoonyoungBaras, Alexander S.Daniels, Marcus J.Lombardo, KaraBrant, AaronMikkilineni, NinaMcConkey, David J.Kamat, Ashish M.Svatek, Robert S.Porten, Sima P.Meeks, Joshua J.Lerner, Seth P.Dinney, Colin P.Black, Peter C.McKiernan, James M.Anderson, ChrisDrake, Charles G.Bivalacqua, Trinity J.
- [26] New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder CancerBLADDER CANCER, 2023, 9 (03) : 237 - 251Asimakopoulos, Anastasios D.Kochergin, MaximColalillo, GaiaFahmy, OmarHassan, FahmyRenninger, MarkusGallioli, AndreaGavrilov, PavelGakis, Georgios
- [27] Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder CancerBLADDER CANCER, 2015, 1 (01) : 65 - 72Steinberg, Ryan L.Thomas, Lewis J.O'Donnell, Michael A.Nepple, Kenneth G.
- [28] SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR THE SALVAGE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCERJOURNAL OF UROLOGY, 2015, 193 (04): : E301 - E301Steinberg, RyanThomas, LewisO'Donnell, MichaelNepple, Kenneth
- [29] A multicenter clinical trial of intravesical BCG in combination with ALT-803 in patients with BCG-unresponsive non-muscle invasive bladder cancer.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)Chamie, KarimSalmasi, AmiraliRosser, Charles JoelRock, AmyFerguson, LydiaWong, Hing C.
- [30] The comparison of different BCG strains in the intravesical treatment of non-muscle invasive urothelial carcinoma of urinary bladder-A real-world practiceJOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (09) : 928 - 934Chen, Yu-KuangHuang, Eric Yi-HsiuChang, Yen-HwaKuo, Junne-YihChung, Hsiao-JenWu, Howard Hung-HaoLin, Tzu-PingLin, Chih-ChiehFan, Yu-HuaHuang, I-ShenLin, Alex T. L.Huang, William J.